Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03289-9
Recent patents relating to systems, methods and compositions for use in synthetic biology.
与合成生物学中使用的系统、方法和组合物有关的最新专利。
{"title":"Synthetic biology","authors":"","doi":"10.1038/s41587-026-03289-9","DOIUrl":"10.1038/s41587-026-03289-9","url":null,"abstract":"Recent patents relating to systems, methods and compositions for use in synthetic biology.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1447-1447"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03323-w
Dario Ummarino
{"title":"On-demand glycemic control by engineered bacteria","authors":"Dario Ummarino","doi":"10.1038/s41587-026-03323-w","DOIUrl":"10.1038/s41587-026-03323-w","url":null,"abstract":"","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1448-1448"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03320-z
{"title":"New model for industry PhDs","authors":"","doi":"10.1038/s41587-026-03320-z","DOIUrl":"10.1038/s41587-026-03320-z","url":null,"abstract":"","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1421-1421"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03304-z
{"title":"Biotech news from around the world","authors":"","doi":"10.1038/s41587-026-03304-z","DOIUrl":"10.1038/s41587-026-03304-z","url":null,"abstract":"","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1422-1422"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s41587-026-03304-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03299-7
Recent moves of note in and around the biotech and pharma industries.
生物技术和制药行业的最新动向。
{"title":"People","authors":"","doi":"10.1038/s41587-026-03299-7","DOIUrl":"10.1038/s41587-026-03299-7","url":null,"abstract":"Recent moves of note in and around the biotech and pharma industries.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1584-1584"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03306-x
Michael Eisenstein
Scientists uncover thousands of previously missed proteins, many of which appear to be relevant to human health — including promising new targets for cancer immunotherapies.
科学家们发现了数千种以前被遗漏的蛋白质，其中许多似乎与人类健康有关，包括癌症免疫疗法的新靶点。
{"title":"Startups mine ‘dark proteome’ for new drug targets","authors":"Michael Eisenstein","doi":"10.1038/s41587-026-03306-x","DOIUrl":"10.1038/s41587-026-03306-x","url":null,"abstract":"Scientists uncover thousands of previously missed proteins, many of which appear to be relevant to human health — including promising new targets for cancer immunotherapies.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1419-1422"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03305-y
Andrew Marshall
A new generation of RNA therapies delivered by lipid nanoparticles takes aim at extrahepatic tissues.
由脂质纳米颗粒递送的新一代RNA疗法瞄准肝外组织。
{"title":"Lipid nanoparticles chart path beyond the liver","authors":"Andrew Marshall","doi":"10.1038/s41587-026-03305-y","DOIUrl":"10.1038/s41587-026-03305-y","url":null,"abstract":"A new generation of RNA therapies delivered by lipid nanoparticles takes aim at extrahepatic tissues.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1415-1418"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03292-0
Vasanthanathan Poongavanam, Mikael Mattsson, Pär Matsson, Per I. Arvidsson, Kristian Sandberg
A scalable blueprint for postdoctoral training embeds entrepreneurial venture mechanics and industry mobility directly into academic infrastructure to cultivate ‘T-shaped’ scientific leaders.
{"title":"The SciLifeLab PULSE entrepreneurial model: accelerating drug discovery by bridging academia and industry","authors":"Vasanthanathan Poongavanam, Mikael Mattsson, Pär Matsson, Per I. Arvidsson, Kristian Sandberg","doi":"10.1038/s41587-026-03292-0","DOIUrl":"10.1038/s41587-026-03292-0","url":null,"abstract":"A scalable blueprint for postdoctoral training embeds entrepreneurial venture mechanics and industry mobility directly into academic infrastructure to cultivate ‘T-shaped’ scientific leaders.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1581-1583"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-10DOI: 10.1038/s41587-026-03280-4
William B. Feldman, Theodore W. Teng, Sumedh Kotrannavar, S. Sean Tu
The FDA cannot approve generic drugs for marketing until brand-name drug patents on its list expire or are successfully challenged, but courts have recently found that certain device-only patents are impermissible and should not be listed.
{"title":"Pharmaceutical products with device-only patents: a cross-sectional analysis","authors":"William B. Feldman, Theodore W. Teng, Sumedh Kotrannavar, S. Sean Tu","doi":"10.1038/s41587-026-03280-4","DOIUrl":"10.1038/s41587-026-03280-4","url":null,"abstract":"The FDA cannot approve generic drugs for marketing until brand-name drug patents on its list expire or are successfully challenged, but courts have recently found that certain device-only patents are impermissible and should not be listed.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 9","pages":"1441-1446"},"PeriodicalIF":44.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148928132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：